AGP Executive Report
Last update: 4 hours agoWHO Leadership: Qatar’s Dr Hanan Al Kuwari has been nominated to succeed Tedros as WHO Director-General, with the election set for May 2027. AI Safety Diplomacy: Bill Gates says he wants to push global rules with China on risky AI releases and even monitoring AI’s ability to create harmful biological agents. Cancer Drug Approvals: The FDA cleared Tevimbra plus Ziihera with chemo for first-line HER2+ gastroesophageal cancers, and approved Tivicay PD (dolutegravir) for HIV-positive children from birth at ≥2 kg. New Pancreatic Cancer Option: The FDA approved daraxonrasib (Rasonque), the first RAS-directed therapy for metastatic pancreatic cancer after prior treatment. Public Health Watch: Hawaiʻi health officials are investigating a likely locally acquired cyclosporiasis case on Oʻahu. Infectious Disease Update: A West Nile virus case in the Netherlands has resulted in a death, with authorities stressing overall risk remains low. Policy & Access: A “Sick of It” tour is spotlighting healthcare coverage gaps after cuts to insurance subsidies. Health Workforce Funding: India approved ₹2,447.98 crore for Andhra Pradesh’s National Health Mission for 2026-27.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
